Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease [Phase 3]
Phase 3 clinical trial update on finerenone showing efficacy and safety in subjects with type 2 diabetes and diabetic kidney disease.
-
FDA approval · 2022-04-15FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental NDA for JENTADUETO (linagliptin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceuticals, Inc.…
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. [Phase 4]
Phase 4 trial comparing combined dapagliflozin and exenatide vs dapagliflozin and placebo in uncontrolled type 2 diabetes assessing ectopic …
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients. [Phase 4]
A Phase 4 trial comparing daily basal insulin titration versus three-times-daily titration to determine which regimen better reduces HbA1c w…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing tirzepatide to dulaglutide in adults with type 2 diabetes has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes
Clinical trial updating investigation of lipoprotein-associated phospholipase A2 in patients with type 2 diabetes has completed with results…
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension [Phase 4]
Phase 4 evaluation of a fixed-dose combination of irbesartan/atorvastatin in type 2 diabetes patients with hyperlipidemia and hypertension h…
-
CLINICAL_TRIALS research · 2022-04-12Clinical Trial Update: The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis [Phase 4]
Phase 4 clinical trial investigating the metabolic effects of liraglutide on postprandial lipids, liver fat, and de novo lipogenesis in type…
-
FDA approval · 2022-04-11FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application to authorize a fixed-dose combination tablet of dapagliflozin and metformin hydrochloride for ty…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL) [Phase 3]
Phase 3 trial evaluating exenatide in combination with insulin to preserve beta-cell function in type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification [Phase 4]
Phase 4 trial update evaluating short-term intensive de-escalation therapy for long-term regimen simplification in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: A Study for Post-Marketing Surveillance of Nesina® Tablet Monotherapy or Combination Therapy in Participants With Type 2 Diabetes (T2DM) in South Korea
Post-marketing surveillance trial for Nesina (alogliptin) monotherapy or in combination for type 2 diabetes in South Korea has completed; re…
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating the efficacy and safety of DWP16001 versus an active comparator in adults with Type 2 Diabetes Mellitus has complet…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial evaluating insulin degludec and insulin glargine U100 for management of hospitalized and discharged patients with typ…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Evaluation of a Patient Portal Intervention for Diabetes: A Pilot Randomized Controlled Trial [NA]
A pilot randomized controlled trial evaluating a patient portal intervention for adults with type 2 diabetes; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update evaluating semaglutide as an adjunct to dieting for type 2 diabetes.
-
FDA approval · 2022-03-28FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
FDA approved Novo Nordisk's supplemental application for Ozempic (semaglutide). The approval updates the product labeling.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin [Phase 3]
Phase 3 trial evaluating JT-003 added to metformin and dapagliflozin in type 2 diabetes mellitus with inadequate control.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Gan & Lee Insulin Glargine Target Type (2) Evaluating Research [Phase 3]
Phase 3 clinical trial update for Gan & Lee Insulin Glargine targeting type 2 diabetes, completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 3]
Phase 3 trial assessing the efficacy and safety of adding dapagliflozin to ongoing metformin and evogliptin in adults with Type 2 diabetes a…
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial evaluating linagliptin response to oral glucose tolerance tests in people with prediabetes and type 2 diabetes completed.
-
FDA label_change · 2022-03-21FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for GLYXAMBI (empagliflozin and linagliptin) from Boehringer Ingelheim Pharmaceuticals, resultin…
-
FDA approval · 2022-03-21FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Synjardy (empagliflozin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharm…
-
FDA approval · 2022-03-21FDA Approved: SYNJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for SYNJARDY XR (empagliflozin/metformin hydrochloride) from Boehringer Ingelheim Pharmaceuticals, I…
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing ticagrelor to aspirin in patients with peripheral artery disease and type 2 diabetes; results posted after complet…